Navigation Links
Response Biomedical Named Medical Device Company of the Year by LifeSciences British Columbia
Date:3/9/2009

VANCOUVER, March 9 /PRNewswire-FirstCall/ - Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) announced that it has been named the Medical Device Company of the Year by LifeSciences British Columbia. This award is presented annually by LifeSciences British Columbia to recognize an organization that has made outstanding contributions to the development of British Columbia's life sciences industry and to increase public awareness and understanding of life sciences in the province. This particular award recognizes a company for execution of business strategies, scientific excellence, leadership and vision and market position/opportunity.

"We are very pleased to be recognized for the contribution and efforts of our whole team in 2008," said S. Wayne Kay, Chief Executive Officer. "We believe we have made outstanding progress in the development, regulatory approval and partnering of our key products in the areas of infectious diseases and cardiovascular diagnostic tests and this award is very much appreciated. There are many fine companies in the life sciences sector in British Columbia and we appreciate being acknowledged amongst our peers for standing out in the achievement of major milestones last year."

About Response Biomedical

Response Biomedical develops, manufactures and markets rapid on-site diagnostic tests for use with its RAMP(R) Platform for clinical and environmental applications. RAMP(R) represents a new paradigm in diagnostics that provides high sensitivity and reliable information in minutes. It is ideally suited to both point of care testing and laboratory use.

The RAMP(R) system consists of a Reader and single-use disposable test cartridges, and has the potential to be adapted to more than 250 medical and non-medical tests currently performed in laboratories. RAMP(R) clinical tests are commercially available for the early detection of heart attack, congestive heart failure and influenza.

In the non-clinical market, RAMP(R) Tests are currently provided for the environmental detection of West Nile Virus, and Biodefense applications including the rapid on-site detection of anthrax, smallpox, ricin and botulinum toxin. Several other product applications are under development. Response has achieved CE Marking for its Reader and clinical tests and its Quality Management System is registered to ISO 13485: 2003 and ISO 9001: 2000. The RAMP(R) Influenza A/B Assay and RAMP 200 reader are not yet licensed for clinical use in Canada.

Response Biomedical is a publicly traded company, listed on the TSX under the trading symbol "RBM" and quoted on the OTC Bulletin Board under the symbol "RPBIF". For further information, please visit the Company's website at www.responsebio.com.

About LifeSciences British Columbia

LifeSciences British Columbia supports and represents the biopharmaceutical, medical device, bioproducts, bioenergy, and greater life sciences community of British Columbia through leadership, advocacy and promotion of British Columbia's world-class science and industry. Via active facilitation of partnering and investment into the life sciences sector, British Columbia is fast becoming a global life sciences leader. LifeSciences British Columbia is a not-for-profit, non-government, industry-funded association.


'/>"/>
SOURCE Response Biomedical Corp.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. AdvaMed Response to the Medical Device Safety Act
2. Ethnicity May Drive Response to Obesity, Insulin Resistance
3. Study Showing Improved Virologic Response with Nitazoxanide in Chronic Hepatitis C Published in Gastroenterology
4. Preparing for the Next Disaster: Dialysis Community Briefs Hill About Emergency Response
5. Statement by American Heart Association President Timothy Gardner, M.D. in Response to Health Proposals in President Obamas Budget
6. Forest Laboratories, Inc. Provides Statement in Response to Complaint Filed by U.S. Government
7. Blunt Response to President Obamas Address
8. St John Ambulance Selects Web-Based SMS Solution From Text Messaging Centre (TMC) for Rapid Response Communication via Two-Way SMS Messaging
9. Team learns how cellular protein detects viruses and sparks immune response
10. Legion Condemns Governors Non-Response to ISSCH Proposal As Slap In The Face
11. FDA Clears New Immune Response Claim for the CryoValve(R) SG Pulmonary Human Heart Valve
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... PA (PRWEB) , ... April 21, 2017 , ... ... firm in Allegheny County that offers services to communities throughout the greater Pittsburgh ... in a charity drive to provide adaptive bicycles for differently-abled children. , Variety ...
(Date:4/21/2017)... City, Colo. (PRWEB) , ... April 21, 2017 , ... ... of the Flex House, the next project in the company’s esteemed VISION House demonstration ... help homeowners use exactly the amount of resources they need to live affordably and ...
(Date:4/21/2017)... ... 21, 2017 , ... The VIA Agency , a ... Theravent, Inc. , the makers of a revolutionary new device clinically proven ... now working to expand distribution in anticipation of a national launch. VIA will ...
(Date:4/21/2017)... Arvada, CO (PRWEB) , ... April 21, 2017 ... ... health and performance system, has partnered with O2X , an active lifestyle ... are focused on improving the health of firefighters, police offers, first responders, military ...
(Date:4/21/2017)... British Columbia (PRWEB) , ... April 21, 2017 , ... ... at treating people who wish to overcome their mental health struggles. The Alive team ... Director Vic LeBouthillier says: “Our approach in dealing with a mental health struggle is ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a ... will be participating in the Deutsche Bank Securities 42nd ... Boston, Massachusetts on Wednesday, May ... Eastern Time. A live webcast of the ... website at http://investor.zimmerbiomet.com .  The webcast will be ...
(Date:4/20/2017)... Mass. , April 20, 2017  RXi ... developing innovative therapeutics that address significant unmet medical ... data from the Company,s consumer product development program, ... at the Society for Investigative Dermatology (SID) 76 ... to advance and promote the sciences relevant to ...
(Date:4/20/2017)... 20, 2017  CVS Pharmacy, the retail division ... new store design to enhance the retail customer ... health-focused products and expanded beauty selections paired with ... discover new offerings. Together with its innovative digital ... the customer experience at CVS Pharmacy.  ...
Breaking Medicine Technology: